Related Experiment Videos
SELDI-TOF proteomic analysis and cancer detection
1Department of Surgery and Molecular Oncology, University of Dundee, Ninewells Hospital and Medical School, Scotland, UK. N.Henderson@dundee.ac.uk
Summary
Surface-enhanced laser-desorption and ionization time-of-flight mass spectrometry (SELDI-TOF MS) shows promise for early cancer detection by identifying novel biomarkers. Further research is needed to ensure reproducibility and standardization for clinical use.
Area of Science:
- Biomarker Discovery
- Proteomics
- Mass Spectrometry
Background:
- Proteomic approaches are increasingly utilized for disease diagnosis.
- Surface-enhanced laser-desorption and ionization time-of-flight mass spectrometry (SELDI-TOF MS) is a promising proteomic technology.
Purpose of the Study:
- To review literature on proteomic technologies for early cancer detection.
- To evaluate the potential of SELDI-TOF MS in cancer diagnostics.
Main Methods:
- Literature review of English language studies.
- Utilized PubMed and Medline databases.
- Focused on studies employing proteomic technologies for cancer detection.
Main Results:
- SELDI-TOF MS is an array-based mass spectrometry technique.
- It identifies and quantifies proteins on a modified surface.
- Numerous novel cancer biomarkers have been discovered using this versatile technology across various tissues and fluids.
Conclusions:
- SELDI-TOF MS studies demonstrate high sensitivity and specificity in discriminating between diseased and healthy individuals.
- Reproducibility, standardization, and feasibility require further investigation.
- These proteomic approaches hold potential for novel, highly sensitive diagnostic tools in clinical care.